317 results
Page 9 of 16
8-K
EX-99.1
h766xv2 o2kgznk
4 Mar 15
Alimera Sciences Reports Fourth Quarter and Full Year 2014 Financial Results
12:00am
8-K
ace1m
4 Mar 15
Alimera Sciences Reports Fourth Quarter and Full Year 2014 Financial Results
12:00am
8-K
EX-99.1
8ih3u
15 Dec 14
Alimera Sciences Announces Closing of $50.0 Million Financing with Deerfield Management
12:00am
8-K
EX-3.6
ox5mimv
15 Dec 14
Alimera Sciences Announces Closing of $50.0 Million Financing with Deerfield Management
12:00am
424B5
ac7un rze6855d
28 Nov 14
Prospectus supplement for primary offering
12:00am
8-K
EX-3.6
fhrzzh
28 Nov 14
Alimera Sciences Announces Agreement with Deerfield Management
12:00am
8-K
EX-99.1
jrs zfmryd4
28 Nov 14
Alimera Sciences Announces Agreement with Deerfield Management
12:00am
8-K
9tk06
6 Nov 14
Alimera Sciences Reports Third Quarter 2014 Financial Results
12:00am
8-K
EX-99.1
govr 9wlj
6 Nov 14
Alimera Sciences Reports Third Quarter 2014 Financial Results
12:00am
8-K
EX-10.54
8kjq gzt8
23 Oct 14
Departure of Directors or Certain Officers
12:00am
8-K
EX-10.55
7rc1mhnp
23 Oct 14
Departure of Directors or Certain Officers
12:00am
8-K
EX-10.53
l3mf9hb b0m9xk
23 Oct 14
Departure of Directors or Certain Officers
12:00am
8-K
4dfj8kxsr5gy3w0mgz
1 Oct 14
Regulation FD Disclosure
12:00am
8-K
chibz1lksxtx
29 Sep 14
Alimera Sciences Provides Details on Fda Approval of IluvienĀ® As the First Long-term Treatment for Diabetic Macular Edema
12:00am
8-K
EX-99.1
xrlzx5g50hw1e0
29 Sep 14
Alimera Sciences Provides Details on Fda Approval of IluvienĀ® As the First Long-term Treatment for Diabetic Macular Edema
12:00am
8-K
EX-99.1
kalwmsb56mh
26 Sep 14
Alimera Sciences Receives Fda Approval for IluvienĀ®, the First Long-term Treatment for Diabetic Macular Edema
12:00am
424B5
ihm5f 6qlq
22 Sep 14
Prospectus supplement for primary offering
12:00am